NCT04884477View on ClinicalTrials.gov

COVID-19 Infection in Patients Receiving Anti-CD20 Therapy

CompletedOBSERVATIONAL

Enrollment

342

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

January 15, 2023

Study Completion Date

January 15, 2023

Conditions

COVID-19Immunosuppressed HostConvalescent PlasmaAnti-CD20 Therapy

Interventions

BIOLOGICAL

Convalescent Plasma

Convalescent Plasma

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT04884477 - COVID-19 Infection in Patients Receiving Anti-CD20 Therapy | Biotech Hunter | Biotech Hunter